| Literature DB >> 24684907 |
Naoyuki Nishiya1, Yusuke Oku2, Yusuke Kumagai2, Yuki Sato2, Emi Yamaguchi2, Akari Sasaki2, Momoko Shoji2, Yukimi Ohnishi2, Hitoshi Okamoto3, Yoshimasa Uehara2.
Abstract
Genetic screening for suppressor mutants has been successfully used to identify important signaling regulators. Using an analogy to genetic suppressor screening, we developed a chemical suppressor screening method to identify inhibitors of the Wnt/β-catenin signaling pathway. We used zebrafish embryos in which chemically induced β-catenin accumulation led to an "eyeless" phenotype and conducted a pilot screening for compounds that restored eye development. This approach allowed us to identify geranylgeranyltransferase inhibitor 286 (GGTI-286), a geranylgeranyltransferase (GGTase) inhibitor. Our follow-up studies showed that GGTI-286 reduces nuclear localization of β-catenin and transcription dependent on β-catenin/T cell factor in mammalian cells. In addition to pharmacological inhibition, GGTase gene knockdown also attenuates the nuclear function of β-catenin. Overall, we validate our chemical suppressor screening as a method for identifying Wnt/β-catenin pathway inhibitors and implicate GGTase as a potential therapeutic target for Wnt-activated cancers.Entities:
Mesh：
Substances：
Year: 2014 PMID： 24684907 DOI： 10.1016/j.chembiol.2014.02.015
Source DB: PubMed Journal: Chem Biol ISSN： 1074-5521